Arlington, United States
Cerbrec, founded in 2023, is blazing a trail in the AI and biopharma sectors with its AI-First Operations Platform. This full-stack solution leverages the power of AI and machine learning to unify workflows, enabling seamless integration and synergistic collaboration among AI agents. Its focus is on optimizing operations and automating resolution, which is critical for enhancing efficiencies in complex environments.
With headquarters in the United States, Cerbrec has successfully attracted significant attention from key players in the industry. Their most recent financial backing occurred as a seed investment on 01 February 2025, featuring notable participation from AIN Ventures and the Virginia Innovation Partnership Corporation. Earlier, they received support from the AWS GenAI Accelerator, SRI International, and Techstars Boston, affirming their strategic relevance and disruptive potential.
